Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target The firm cited ...
Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target Maximize Your Portfolio ...
Cantor Fitzgerald Investment Advisors L.P. decreased its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 1.6% in the fourth quarter, according to its most recent 13F filing with ...
Cantor Fitzgerald adjusted its outlook on Informatica (NYSE:INFA) shares by lowering the price target to $18.00 from the ...
Cantor Fitzgerald analyst Brett Knoblauch reaffirmed an Overweight rating on Udemy Inc (NASDAQ:UDMY), with a steady price target of $11.00. This target aligns with broader market sentiment, as ...
Verisign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, has revealed the retirement of George E. Kilguss III, the Executive Vice ...
Yahoo Finance/Marist Poll survey reveals Americans' biggest barriers to saving and how they feel about their finances heading into 2025. Balance transfers help you repay debt using an introductory ...
The president continues to press his effort to remake global trade to address what he says is a system that is tilted against the US. “If the US is not willing, if it is bent on suppressing and ...
Trusted by 150+ million investors each month, your ideas have shaped the most popular finance destination.¹ Explore what you can do with news, data, and tools designed to help you make financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results